In order to investigate the accuracy and practicability of the polymerase chain reaction (PCR) in the antenatal diagnosis of congenital toxoplasmosis, a collaborative study involving 15 European laboratories was performed under the auspices of the Biomed 2 Programme of the European Community. Each team received 12 aliquots (four negative, eight positive) of`artificial samples' made of amniotic fluid spiked with tachyzoites of the RH strain of Toxoplasma gondii. Each team performed its own PCR protocol (all were different). Nine of the 15 laboratories were able to detect a single parasite, but two of the 15 found all samples negative. Four of the 15 laboratories found one or more control samples to be falsely positive. This study highlights the lack of homogeneity between PCR protocols and performance and underlines the need for an external quality assurance scheme which could provide`reference' samples that could be used by any laboratory wanting to establish and maintain an accurate diagnostic test based on PCR. z
Introduction
Gene ampli¢cation methods are becoming increasingly widely used in the routine diagnosis of infectious diseases, but their use remains di¤cult, especially for laboratories without specialist expertise in molecular biology. Furthermore, when the diagnosis is performed on antenatal samples (amniotic £uid) where misdiagnosis of congenital infectious diseases can have profound consequences on the outcome of the fetus, the need for the evaluation of PCR protocols used for routine laboratory investigations is urgent. This is particularly the case for toxoplasmosis, where a number of studies have con¢rmed the potential of PCR in suspected congenital infection and in the immunocompromised [1^6] . A pilot ¢ve-laboratory study (performed under the auspices of a European Community-funded Biomed programme) involving detection of Toxoplasma gondii DNA in amniotic £uid samples identi¢ed signi¢cant di¡eren-ces in performance in the PCR methods used and highlighted a number of technical di¡erences in protocols [7] . The aim of the present study, organized by the European Network on Congenital Toxoplasmosis (ENCT, Coordinator: E. Petersen, Copenhagen, Denmark) granted by the Biomed 2 Programme of the EC, is to investigate whether such a situation exists more widely within European laboratories and to con¢rm whether particular PCR methodologies might be associated with improved diagnostic accuracy.
Materials and methods

Samples
The arti¢cial samples were made as follows: amniotic £uid (con¢rmed PCR negative for T. gondii) were collected from six of the European centers who are members of the ENCT and involved in the study. These PCR-negative samples were then pooled. It should be emphasised that the team which prepared the arti¢cial samples also participated in the ¢rst European study [7] and that their PCR method performed with a high level of sensitivity. Tachyzoites of the RH strain of T. gondii were harvested from peritoneal exudate of Swiss mice intraperitoneally infected 3 days before, washed and counted using a Mallassez hemocytometer. Then amniotic £uid was spiked or not with the tachyzoites and dilutions were performed (serial dilution of a ¢rst solution containing 10 U tachyzoites/ml) in order to make 12`arti¢cial samples' consisting of four negative samples, two samples with 1 tachyzoite/ml, two with 10 tachyzoites/ml, two with 100 tachyzoites/ml, and two with 1000 tachyzoites/ml. Aliquots (1 ml) of each of these 12 samples were then coded and stored at 320³C until distribution to each of the 15 participating laboratories.
Transport of samples
Shipment was made on dry ice to avoid thawing. Using a 24-h delivery service, no team reported the problem of thawing on receipt of their aliquots.
PCR protocols
In this study, each team utilised its own PCR technique. Some of the techniques have been published previously [8^13] . The 15 protocols used are summarized in Table 1 .
Results
The results obtained by each of the 15 teams are reported in Table 2 . Brie£y, two of the 15 laboratories (J, N) identi¢ed all 12 samples (eight positive and four negative) correctly, while three teams (C, F, O) only failed to identify correctly one of the phen^chlor, phenol^chloroform extraction ; prot k, proteinase K lysis. Pretreatment of samples with a proteinase is a part of the commercial DNA extraction method of Qiagen. Location (base pair numbers on the target gene sequence) of the two primers (single PCR) or of the two pairs of primers (nested PCR) used to amplify the target sequence. A positive control amplicon was produced concurrently and in the same reaction tube as the test amplicon by the addition of a control sequence of target DNA. This control DNA may either be an arti¢cial DNA construct containing the primer sequences, ampli¢ed by the test primers (internal control), or a de¢ned sequence of DNA ampli¢ed by a second primer pair, e.g. L-globin (external control).
samples containing a single tachyzoite. Thus, the lower detection limit of these ¢ve laboratories (C, F, O, J, N) was one parasite. Two of the 15 laboratories (L, M) identi¢ed all samples correctly, apart from the two samples containing a single parasite, although laboratory L did identify both of these as equivocal' (lower detection limit 10 parasites). Four laboratories (B, D, G, K) were unable to identify any of the samples containing less than 100 tachyzoites (two of these, B and G, found all samples negative). Four of the 15 laboratories found at least one negative control to be falsely positive: E, H and I recorded one false positive and A had four false positives.
The study protocol required laboratories only to indicate results as positive or negative. However, some laboratories (C, E, F, L, O) also provided semi-quantitative results for positive samples and these are shown in the Table 1. A wide variety of procedures for sample preparation (pretreatment, centrifugation speed, DNA extraction) of the target gene, and of PCR procedure were performed in the di¡erent laboratories. Only one laboratory used uracyl-N-glycosylase to avoid contamination with amplicons. No information was gathered concerning other measures taken to prevent contamination. Only three of the 15 laboratories monitored the presence of inhibitors of the PCR by internal or external positive controls.
It should be emphasised that the code (A to O) attributed to laboratories does not correlate to the order of laboratories as listed on the title page. The ¢rst result was given by one laboratory 1 week after receiving the aliquots, the last almost 5 months after.
Discussion
A previous preliminary European collaborative study on PCR for toxoplasmosis involving only ¢ve centers identi¢ed signi¢cant di¡erences in test performance [7] . As a result, it was concluded that a follow-up study was required involving a larger number of laboratories to investigate whether this potential problem was more widespread. Furthermore, a larger study incorporating collection of information on PCR protocols and correlation with overall laboratory performance might yield insight into optimal methods for routine PCR. The present study, incorporating a larger number of laboratories (15) and collecting more detailed information on methods employed, aimed to address these issues. Furthermore, the inclusion of whole tachyzoites instead of T. gondii DNA (making arti¢cial samples more representative of the situation with naturally infected amniotic £uid) attempted to address the issue of DNA stability. The series of aliquots were sent frozen to the participating teams in order to avoid possible degradation of DNA during transportation, although most of the teams perform PCR on non-frozen samples. In practice, the problem in such a study is to choose between the risk of DNA degradation (unfrozen samples) if the shipment is delayed or if the participating team cannot perform PCR immediately, and that thawing may disrupt Toxoplasma tachyzoites before the lysis step of the PCR protocol, possibly in£uencing PCR results [14] . Overall, the results of this study are consistent with those found previously. False negative (at least one negative result among the eight aliquots with a positive result expected) and/or false positive (at least one of the four negative controls found positive) results were reported. However, one practical problem relating to the methodology of the present study is the di¤culty of preparing arti¢cial samples so that they contain a single parasite. Clearly, when using a method where cells are counted in a stock solution and then diluted, there is a potential risk for inaccuracy due to the heterogenous distribution of tachyzoites in suspensions. Twelve of the 22 samples that we considered to contain one tachyzoite and that were tested by laboratories able to detect at least 10 parasites in the other aliquots were found positive. This suggests that a signi¢cant proportion of the`one-tachyzoite' aliquots did contain at least one tachyzoite, but we cannot exclude the possibility that some of the other`one-tachyzoite' aliquots found negative by PCR may not have contained a tachyzoite. However, the presence of false positive results (11% of the negative control samples, four of the 15 teams) clearly con¢rms that, on this particular point, the PCR protocols should be improved. Surprisingly, only one team reported the use of uracyl-N-glycosylase. Taken together, these results emphasize that even if PCR is a very sensitive and useful technique, it should not be used alone for the diagnosis of Toxoplasma infection of fetuses using amniotic £uid. Until the establishment of an appropriate quality assurance scheme, we would recommend that PCR be used in association with other laboratory methods, such as mice inoculation and in vitro culture.
To investigate whether any particular technical steps of the PCR protocols could be linked with false positive or false negative results, a questionnaire (16 items) addressing the main steps of the protocols used was sent to the 15 laboratories. Analysis of the replies indicated no clear links between PCR methodology and performance. However, it could be noted that in laboratories with no false positive results or false negative results for aliquots with only one parasite, the DNA extraction protocols used mainly classical phenol^chloroform or boiling methods (laboratory C excepted, which used a commercial kit). In teams with both false positive and false negative results, two of the four teams performed no extraction, and no teams used uracyl-N-glycosylase decontamination. It was also noted that two of the four using nested PCR obtained both false positive and false negative results, compared with one of the three teams with no false positive or false negative results. It seems that, generally, the protocols which give the best results seem to be those with the fewer separate procedures and handling steps.
In the absence of any clear correlation between methodology and performance of PCR, we conclude that another possible explanation for the observed discrepancies in performance is technical pro¢ciency. However, inadequate internal quality control of any steps of each PCR method (such as DNA extraction, accuracy of PCR machines) cannot be excluded.
The results of our study are consistent with the results of both a previous smaller one [7] concerning T. gondii and others involving PCR for other microorganisms [15] . In our previous study [7] , it was concluded that the inclusion of puri¢ed T. gondii DNA in samples may have caused some laboratory protocols (optimized for clinical specimen) to perform suboptimally. Thus, an important re¢nement of the present study is the inclusion of samples containing whole parasites, making these more representative of clinical specimens. Furthermore, no study on this topic has been performed on such a large scale to our knowledge. The results highlight the fact that there are no identical protocols among the 15 and the urgent need for standardization of PCR protocols, and also possibly accreditation of diagnostic laboratories. This would be complemented by the existence of a`reference' sample bank to which any laboratory could refer when an evaluation of a PCR technique is needed. From a practical point of view, our study demonstrates the need for laboratories to use all the technical parameters necessary to avoid false positive (separate rooms, decontamination systems) and false negative (use of internal controls to di¡erentiate negative results and the presence of inhibitors) results. However, as demonstrated in this study, the results are dependent on the addition of all the technical steps, not of a single one, which emphasizes the need for an internal and an external evaluation of the technique after any modi¢cation. Furthermore, the di¡erences in PCR design and potential discrepancies in performance of PCR highlighted by this study underline the caution required in applying ¢ndings (particularly PCR sensitivity and speci¢city) from other published clinical studies using di¡erent PCR methodologies [16] , even if, globally, PCR represents the major improvement in the ¢eld of microbiological diagnosis (and particularly for toxoplasmosis) in the 10 past years.
